Patents
U.S. SUPREME COURT REFUSES TO HEAR CASE IN WHICH TLO INVALIDATED WHIRLPOOL’S PATENT
Posted in / Patents / - on July 13, 2018
Homeland Housewares LLC, the maker of the world famous NutriBullet blender, has prevailed in a patent dispute against Whirlpool Corporation. The case began as a challenge to the validity of Whirlpool’s 7,581,688 patent before the Patent Trial and Appeal Board (PTAB). The case concluded on June 4, 2018 when the Supreme Court denied Whirlpool’s petition… read more
Congratulations to Woodham Biotechnology Holdings, LLC!
Posted in / Patents / - on October 29, 2017
Congratulations to Woodham Biotechnology Holdings, LLC for receiving its second and most critical patent for its breakthrough technology involving protein electrophoresis. For decades, scientists have gone through a tedious two step process of first separating proteins, followed by protein blotting of the results of the first step. Gels used in the first step can fall… read more
Congratulations to Dr. Owiesy!
Posted in / Patents / - on October 28, 2017
Congratulations to Dr. Owiesy for receiving his patent for his cure for migraine headaches. You read that right. Dr. Owiesy invented a cure. Dr. Oweisy has had amazing success in curing his patients of re-occurring migraines. After one to two treatments, the migraines do not return.
Congratulations to Our Favorite Canadians at Automotive Data Solutions, Inc. and to Mark Rutledge!
Posted in / Patents / - on October 27, 2017
Congratulations to our favorite Canadians at Automotive Data Solutions, Inc. and to Mark Rutledge, their token American engineer, for two new patents for a graphical interface and new router for vehicle stereo systems. These patents are for inventions that make up a part of the most creative and sophisticated Internet-based platform in the aftermarket automotive… read more
PATENT RIGHTS LOST FOR CANCER DRUG
Posted in / Patents / - on May 9, 2017
On May 1, 2017, the Federal Circuit Court of Appeals issued a decision in which Helsinn Healthcare S.A. lost its patent rights to its drug for reducing chemotherapy-induced nausea and vomiting. See Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., Case Nos. 2016-1284, 2016-1787. The patented drug was sold under the trade names Aloxi® and… read more
Why you need a patent opinion
Posted in / Patents, Uncategorized / - on January 19, 2017
1. What is a legal opinion and why you might need one A legal opinion is indispensible in helping you make the right business decision and, often, it will provide needed coverage should you face litigation. In essence, it is our formal advice as experienced registered Los Angeles patent attorneys on the applicability of the… read more
TLO® INSIGHT: Patents Can Now Be Held Unenforceable for the Actions of Management Not Directly Involved in the Patent Process
Posted in / Patents, Uncategorized / - on January 19, 2017
In the usual case, claims of inequitable conduct revolve around inventors or patent attorneys who fail to disclose material prior art as they prosecute a patent application. However, the Federal Circuit has now held that where a company has submitted a patent application, the president of that company may owe a duty to disclose prior… read more
TLO® INSIGHT: How To Fight A Patent Troll
Posted in / Patents, Uncategorized / - on January 19, 2017
Companies seeking to license their patent rights take many forms. One of those companies is Sorensen Research and Development Trust. Your company may have received a cease and desist letter from Sorensen demanding several hundred thousand dollars. You are probably first wondering, who is Sorensen? Sorensen has a portfolio of patents relating to plastic molding technology…. read more
TLO® INSIGHT: Federal Court Throws Patentability of Genes in Doubt
Posted in / Patents, Uncategorized / - on January 19, 2017
In a decision that surprised the legal and scientific communities alike, a federal court in the Southern District of New York has held that all of the claims at issue in seven of Myriad Genetics, Inc.’s breast cancer gene patents are invalid, including those directed toward methods of using isolated genes as markers for breast… read more
ARE YOUR PATENT RIGHTS DYING TOO YOUNG?
Posted in / Patents, Uncategorized / - on January 18, 2017
TOO MANY MEDICAL DEVICE PATENTS DIE BEFORE THEIR TIME Your company has worked hard to make your first orthopedic device a commercial success. Overcoming numerous technological obstacles and addressing the FDA’s concerns took years of hard work. Once it was finally approved by the FDA, your company still plowed a good percentage of the profits from… read more